STOCK TITAN

Indivior Announces Completion of Cancellation of Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Indivior (Nasdaq: INDV) has completed the cancellation of its secondary listing on the London Stock Exchange effective July 25, 2025 at 8:00 a.m. UK time. The delisting includes the removal from both the UK Financial Conduct Authority's Official List and the London Stock Exchange's main market for listed securities.

The company will maintain its primary listing on the Nasdaq Stock Market. To assist shareholders with this transition, Indivior has made available an FAQ document on their investor relations website.

Indivior (Nasdaq: INDV) ha completato la cancellazione della sua quotazione secondaria alla Borsa di Londra, con effetto dal 25 luglio 2025 alle ore 8:00 (ora del Regno Unito). La rimozione riguarda sia l'elenco ufficiale della Financial Conduct Authority del Regno Unito sia il mercato principale della Borsa di Londra per i titoli quotati.

La società manterrà la sua quotazione primaria sul Nasdaq Stock Market. Per agevolare gli azionisti in questa transizione, Indivior ha reso disponibile un documento FAQ sul sito web delle relazioni con gli investitori.

Indivior (Nasdaq: INDV) ha completado la cancelación de su cotización secundaria en la Bolsa de Londres, con efecto a partir del 25 de julio de 2025 a las 8:00 a.m., hora del Reino Unido. La exclusión incluye la eliminación tanto de la Lista Oficial de la Autoridad de Conducta Financiera del Reino Unido como del mercado principal de la Bolsa de Londres para valores cotizados.

La compañía mantendrá su cotización primaria en el Nasdaq Stock Market. Para ayudar a los accionistas con esta transición, Indivior ha puesto a disposición un documento de preguntas frecuentes en su sitio web de relaciones con inversores.

Indivior (나스닥: INDV)는 2025년 7월 25일 오전 8시(영국 시간)를 기점으로 런던 증권거래소에서의 2차 상장을 공식적으로 취소하였습니다. 이번 상장 폐지는 영국 금융감독청의 공식 명부와 런던 증권거래소 주요 시장에서의 상장 모두에서의 제거를 포함합니다.

회사는 나스닥 증권거래소에서의 1차 상장을 유지할 예정입니다. 주주들이 이 전환을 원활히 할 수 있도록 Indivior는 투자자 관계 웹사이트에 FAQ 문서를 제공하고 있습니다.

Indivior (Nasdaq : INDV) a finalisé la radiation de sa cotation secondaire à la Bourse de Londres, effective à partir du 25 juillet 2025 à 8h00, heure du Royaume-Uni. Cette radiation comprend la suppression de la liste officielle de la Financial Conduct Authority du Royaume-Uni ainsi que du marché principal de la Bourse de Londres pour les titres cotés.

La société conservera sa cotation principale sur le Nasdaq Stock Market. Pour accompagner les actionnaires dans cette transition, Indivior a mis à disposition un document FAQ sur son site internet dédié aux relations investisseurs.

Indivior (Nasdaq: INDV) hat die Streichung seiner Sekundärnotierung an der Londoner Börse zum 25. Juli 2025 um 8:00 Uhr britischer Zeit abgeschlossen. Die Delistung umfasst die Entfernung sowohl aus der offiziellen Liste der britischen Finanzaufsichtsbehörde als auch vom Hauptmarkt der Londoner Börse für gelistete Wertpapiere.

Das Unternehmen behält seine Primärnotierung an der Nasdaq-Börse bei. Um den Aktionären den Übergang zu erleichtern, hat Indivior ein FAQ-Dokument auf seiner Investor-Relations-Website bereitgestellt.

Positive
  • None.
Negative
  • Reduced access for UK investors
  • Potential decrease in trading liquidity from single-market listing

SLOUGH, United Kingdom and RICHMOND, Va., July 25, 2025 /PRNewswire/ -- Further to the announcement made on June 2, 2025, Indivior PLC (Nasdaq: INDV) today announces that: (i) the secondary listing of the Company's Ordinary Shares ("Ordinary Shares") on the Equity Shares (Transition) category of the Official List of the UK Financial Conduct Authority; and (ii) the admission to trading of its Ordinary Shares on the London Stock Exchange's  main market for listed securities, have now been cancelled with effect from 08:00 a.m. UK time today, July 25, 2025 (the "London Delisting"). Indivior continues to maintain its primary listing of Ordinary Shares on the Nasdaq Stock Market.

Indivior has prepared an FAQ document for shareholders in connection with the London Delisting, which is available at https://www.indivior.com/en/investors/shareholder-information

About Indivior

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients around the world will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a global human crisis to a recognized and treated chronic disease. 

Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in the United States in Richmond, VA, Indivior employs over 1,000 individuals globally and its portfolio of products is available in over 30 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior. 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/indivior-announces-completion-of-cancellation-of-secondary-listing-on-london-stock-exchange-primary-listing-on-nasdaq-to-be-maintained-302513759.html

SOURCE Indivior PLC

FAQ

When did Indivior (INDV) delist from the London Stock Exchange?

Indivior delisted from the London Stock Exchange on July 25, 2025 at 8:00 a.m. UK time.

Where are Indivior shares now traded after the London delisting?

Indivior shares continue to maintain their primary listing on the Nasdaq Stock Market under the symbol INDV.

How can shareholders find information about Indivior's London Stock Exchange delisting?

Shareholders can access an FAQ document about the delisting on Indivior's website at www.indivior.com/en/investors/shareholder-information.

Why did Indivior delist from the London Stock Exchange?

While not explicitly stated in the press release, the delisting appears to be part of a strategic move to simplify the company's listing structure by maintaining only its Nasdaq presence.
Indivior

NASDAQ:INDV

INDV Rankings

INDV Latest News

INDV Latest SEC Filings

INDV Stock Data

2.11B
119.93M
4.09%
92.26%
1.66%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SLOUGH, BERKSHIRE